AI Article Synopsis

  • Nicolau syndrome is a rare complication that can occur after receiving certain drug injections, traditionally reported with various types of injections but not previously associated with intramatricial injections.
  • An 18-year-old male experienced Nicolau syndrome after seven intramatricial injections, leading to symptoms that required treatment with antibiotics, vasodilators, analgesics, and daily dressings.
  • The patient's condition improved significantly, with complete resolution of symptoms and color return to the affected digit by day 21, highlighting the need for awareness among dermatologists regarding this syndrome.

Article Abstract

Nicolau syndrome (Embolia cutis medicamentosa) is a rare complication following parenteral administration of a drug. It has been reported in association with intramuscular, subcutaneous, intravenous and intra-articular injections. However, Nicolau syndrome following intramatricial injection has not been described to the best of our knowledge. We report the case of an 18-year-old male who developed this complication following 7 session of intramatricial injection. The patient was started on broad spectrum antibiotic coverage, vasodilator therapy, analgesics, and daily dressing. On day 21, the symptoms completely resolved with return of normal color of the digit. The case is being reported to make dermatologists aware of the possibility of Nicolau syndrome following intramatricial injection of triamcinolone acetonide.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621196PMC
http://dx.doi.org/10.4103/idoj.IDOJ_333_16DOI Listing

Publication Analysis

Top Keywords

nicolau syndrome
16
syndrome intramatricial
12
intramatricial injection
12
nicolau
4
intramatricial
4
intramatricial triamcinolone
4
injection
4
triamcinolone injection
4
injection nail
4
nail lichen
4

Similar Publications

Post-Coronavirus Disease 2019 (post-COVID-19) syndrome represents a cluster of persistent symptoms following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection that can severely affect quality of life. The pathogenic mechanisms and epidemiology in different regions are still under evaluation. To assess the outcomes of post-COVID-19 syndrome, we performed a questionnaire-based, cross-sectional study in previously infected individuals.

View Article and Find Full Text PDF

Treatment of patients with myocardial ischemic diseases crucially involves cardiac reperfusion (CR). However, oxidative stress and tissue lesions caused by CR may also lead to lethal complications, such as arrythmias and vasoplegic syndrome (VS). Although methylene blue (MB) has long been used to treat VS due to cardiac ischemia and reperfusion (CIR) and/or surgery because of its vascular effects, MB's effects on the heart are unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the best revascularization method for diabetic patients with multivessel disease who experience a non-ST-segment elevation myocardial infarction (NSTEMI), comparing coronary artery bypass grafting (CABG) and multivessel percutaneous coronary intervention (PCI).
  • It involves a large cohort of over 11,000 patients and reveals that CABG is linked to lower all-cause mortality than PCI, particularly in patients deemed potentially ineligible for CABG after a surgical consultation.
  • The results suggest that while CABG is generally more beneficial for these patients, the advantage is more pronounced when comparing CABG to a specific group of PCI patients who had a surgical consultation beforehand.
View Article and Find Full Text PDF
Article Synopsis
  • Neurogenetic disorders linked to mutations in spectrin genes lead to a wide range of symptoms, from peripheral nervous system issues to complex syndromes, emphasizing their diverse impact.
  • An international study identified 14 families with unexplained distal weakness due to heterozygous loss-of-function variants, collecting standardized clinical and imaging data to analyze the condition further.
  • The research found that all 20 patients exhibited early childhood onset of distal weakness with varying severity, along with associated foot abnormalities and muscle changes, confirming the link between these genetic variants and a new syndrome characterized by primarily myogenic effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!